A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

Clinical trial NCT02684006 · COMPLETED

Trial details

NCT number: NCT02684006
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Cell Cancer

Start date: 2016-03-23
Primary completion: 2023-08-31
Enrollment: 886

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.